FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans
Coronavirus,FDA,Coronavirus Vaccine,Pfizer,Moderna,Science,Public Health,CDC,Omicron Variant
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.
Reporting by Michael Erman in New Jersey and Manojna Maddipatla in Bangaluru, Additional reporting by Ahmed Aboulenein in Washington; Editing by Bill Berkrot
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Headline Roundup
Former Fauci Adviser David Morens Pleads Guilty in COVID-19 Records Case
August 19th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Trump Administration Weighs Visa Revocations for Foreigners Who Apply for Asylum
August 25th, 2026
Announcement
The AllSides Student Journalism Award Opens Sept. 1
AllSides Staff
August 24th, 2026
